Company Filing History:
4 out of 1,553 
2 out of 376 
1 out of 3,539 
Years Active: 2005-2018
Title: Edward I Ginns: Innovator in Neuropsychiatric Disorders and Enzyme Deficiencies
Introduction
Edward I Ginns is a notable inventor based in Shrewsbury, MA (US). He has made significant contributions to the fields of neuropsychiatric disorders and lysosomal enzyme deficiencies. With a total of 5 patents, Ginns has focused on developing innovative therapeutic methods that address critical health issues.
Latest Patents
Ginns' latest patents include groundbreaking work on aberrant sonic hedgehog signaling in neuropsychiatric disorders. This patent outlines methods for treating and diagnosing psychiatric affective disorders associated with aberrant Sonic Hedgehog (Shh) signaling. The treatment involves administering a therapeutically effective amount of an antagonist to Smoothened (Smo), an antagonist to Patched-1 (Ptch-1), and/or an antagonist to Shh. Another significant patent focuses on therapy for lysosomal enzyme deficiencies. This invention provides a therapeutic delivery system that includes an extracted yeast cell wall comprising beta-glucan, a payload trapping molecule, and a payload molecule. The system is designed to supplement the function of deficient lysosomal enzymes, offering new hope for patients with these conditions.
Career Highlights
Throughout his career, Ginns has worked with prestigious institutions such as the University of Massachusetts and the University of Miami. His research has led to advancements in understanding and treating complex medical conditions, showcasing his dedication to improving patient outcomes.
Collaborations
Ginns has collaborated with notable colleagues, including Marzena Galdzicka and Gary R Ostroff. These partnerships have contributed to the success of his research and the development of his patents.
Conclusion
Edward I Ginns stands out as an innovative inventor whose work has the potential to transform the treatment of neuropsychiatric disorders and lysosomal enzyme deficiencies. His contributions to science and medicine continue to pave the way for future advancements in these critical areas.